Placebo-controlled Efficacy and Safety Trial of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS)
Phase of Trial: Phase III
Latest Information Update: 25 Sep 2019
Price : $35 *
At a glance
- Drugs Neridronic acid (Primary)
- Indications Complex regional pain syndromes
- Focus Registrational; Therapeutic Use
- Sponsors Grunenthal
- 12 Aug 2019 Status changed from active, no longer recruiting to discontinued.
- 05 Jul 2019 Status changed from recruiting to active, no longer recruiting.
- 18 Jun 2018 New trial record